{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T10:23:54Z","timestamp":1791887034866,"version":"4.3.4"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,12,21]],"date-time":"2015-12-21T00:00:00Z","timestamp":1450656000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature Nanotech"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1038\/nnano.2015.292","type":"journal-article","created":{"date-parts":[[2015,12,21]],"date-time":"2015-12-21T11:50:45Z","timestamp":1450698645000},"page":"295-303","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":458,"title":["In situ vaccination with cowpea mosaic virus nanoparticles suppresses metastatic cancer"],"prefix":"10.1038","volume":"11","author":[{"given":"P. H.","family":"Lizotte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. M.","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. R.","family":"Sheen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Fields","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Rojanasopondist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. F.","family":"Steinmetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Fiering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,12,21]]},"reference":[{"key":"BFnnano2015292_CR1","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nrc3239","volume":"12","author":"DM Pardoll","year":"2012","unstructured":"Pardoll, D. M. The blockade of immune checkpoints in cancer immunotherapy. Nat. Rev. Cancer 12, 252\u2013264 (2012).","journal-title":"Nat. Rev. Cancer"},{"key":"BFnnano2015292_CR2","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/nrc3565","volume":"13","author":"MH Kershaw","year":"2013","unstructured":"Kershaw, M. H., Westwood, J. A. & Darcy, P. K. Gene-engineered T cells for cancer therapy. Nat. Rev. Cancer 13, 525\u2013541 (2013).","journal-title":"Nat. Rev. Cancer"},{"key":"BFnnano2015292_CR3","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1158\/0008-5472.CAN-13-0777","volume":"74","author":"OA Ali","year":"2014","unstructured":"Ali, O. A. et al. Identification of immune factors regulating antitumor immunity using polymeric vaccines with multiple adjuvants. Cancer Res. 74, 1670\u20131681 (2014).","journal-title":"Cancer Res"},{"key":"BFnnano2015292_CR4","doi-asserted-by":"crossref","unstructured":"Callahan, M. K., Postow, M. A. & Wolchok, J. D. CTLA-4 and PD-1 pathway blockade: combinations in the clinic. Front. Oncol. 4, ( 2015).","DOI":"10.3389\/fonc.2014.00385"},{"key":"BFnnano2015292_CR5","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1158\/2326-6066.CIR-14-0215","volume":"3","author":"R Winograd","year":"2015","unstructured":"Winograd, R. et al. Induction of T cell immunity overcomes complete resistance to PD-1 and CTLA-4 blockade and improves survival in pancreatic carcinoma. Cancer Immunol. Res. 3, 399\u2013411 (2015).","journal-title":"Cancer Immunol. Res"},{"key":"BFnnano2015292_CR6","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1056\/NEJMoa1104621","volume":"364","author":"C Robert","year":"2011","unstructured":"Robert, C. et al. Ipilimumab plus dacarbazine for previously untreated metastatic melanoma. N. Engl. J. Med. 364, 2517\u20132526 (2011).","journal-title":"N. Engl. J. Med"},{"key":"BFnnano2015292_CR7","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1200\/JCO.2014.58.3377","volume":"33","author":"RHI Andtbacka","year":"2015","unstructured":"Andtbacka, R. H. I. et al. Talimogene laherparepvec improves durable response rate in patients with advanced melanoma. J. Clin. Oncol. 33, 2780\u20132788 (2015).","journal-title":"J. Clin. Oncol."},{"key":"BFnnano2015292_CR8","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.celrep.2015.04.031","volume":"11","author":"L Corrales","year":"2015","unstructured":"Corrales, L. et al. Direct activation of STING in the tumor microenvironment leads to potent and systemic tumor regression and immunity. Cell Rep. 11, 1018\u20131030 (2015).","journal-title":"Cell Rep"},{"key":"BFnnano2015292_CR9","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1002\/wnan.1274","volume":"6","author":"MR Sheen","year":"2014","unstructured":"Sheen, M. R., Lizotte, P. H., Toraya-Brown, S. & Fiering, S. Stimulating antitumor immunity with nanoparticles. WIREs Nanomed. Nanobiotechnol. 6, 496\u2013505 (2014).","journal-title":"WIREs Nanomed. Nanobiotechnol"},{"key":"BFnnano2015292_CR10","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.1016\/j.vaccine.2012.01.087","volume":"30","author":"SA Halperin","year":"2012","unstructured":"Halperin, S. A. et al. Comparison of safety and immunogenicity of two doses of investigational hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide and three doses of a licensed hepatitis B vaccine in healthy adults 18\u201355 years of age. Vaccine 30, 2556\u20132563 (2012).","journal-title":"Vaccine"},{"key":"BFnnano2015292_CR11","doi-asserted-by":"publisher","first-page":"e0120152","DOI":"10.1371\/journal.pone.0120152","volume":"10","author":"B Huber","year":"2015","unstructured":"Huber, B. et al. A chimeric 18L1-45RG1 virus-like particle vaccine cross-protects against oncogenic alpha-7 human papillomavirus types. PLoS ONE 10, e0120152 (2015).","journal-title":"PLoS ONE"},{"key":"BFnnano2015292_CR12","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.2217\/nnm.14.107","volume":"9","author":"A Rynda-Apple","year":"2014","unstructured":"Rynda-Apple, A., Patterson, D. P. & Douglas, T. Virus-like particles as antigenic nanomaterials for inducing protective immune responses in the lung. Nanomed. 9, 1857\u20131868 (2014).","journal-title":"Nanomed"},{"key":"BFnnano2015292_CR13","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.ajpath.2012.03.018","volume":"181","author":"A Rynda-Apple","year":"2012","unstructured":"Rynda-Apple, A. et al. Virus-like particle-induced protection against MRSA pneumonia is dependent on IL-13 and enhancement of phagocyte function. Am. J. Pathol. 181, 196\u2013210 (2012).","journal-title":"Am. J. Pathol"},{"key":"BFnnano2015292_CR14","doi-asserted-by":"publisher","first-page":"e7142","DOI":"10.1371\/journal.pone.0007142","volume":"4","author":"JA Wiley","year":"2009","unstructured":"Wiley, J. A. et al. Inducible bronchus-associated lymphoid tissue elicited by a protein cage nanoparticle enhances protection in mice against diverse respiratory viruses. PLoS ONE 4, e7142 (2009).","journal-title":"PLoS ONE"},{"key":"BFnnano2015292_CR15","doi-asserted-by":"publisher","first-page":"3036","DOI":"10.1021\/nn4006544","volume":"7","author":"DP Patterson","year":"2013","unstructured":"Patterson, D. P., Rynda-Apple, A., Harmsen, A. L., Harmsen, A. G. & Douglas, T. Biomimetic antigenic nanoparticles elicit controlled protective immune response to influenza. ACS Nano 7, 3036\u20133044 (2013).","journal-title":"ACS Nano"},{"key":"BFnnano2015292_CR16","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/eji.201343587","volume":"44","author":"LE Richert","year":"2014","unstructured":"Richert, L. E. et al. CD11c+ cells primed with unrelated antigens facilitate an accelerated immune response to influenza virus in mice. Eur. J. Immunol. 44, 397\u2013408 (2014).","journal-title":"Eur. J. Immunol"},{"key":"BFnnano2015292_CR17","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.virol.2009.08.023","volume":"393","author":"K Saunders","year":"2009","unstructured":"Saunders, K., Sainsbury, F. & Lomonossoff, G. P. Efficient generation of cowpea mosaicvirus empty virus-like particles by the proteolytic processing of precursors in insect cells and plants. Virology 393, 329\u2013337 (2009).","journal-title":"Virology"},{"key":"BFnnano2015292_CR18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1021\/mp3002057","volume":"10","author":"AAA Aljabali","year":"2013","unstructured":"Aljabali, A. A. A., Shukla, S., Lomonossoff, G. P., Steinmetz, N. F. & Evans, D. J. CPMV-DOX delivers. Mol. Pharm. 10, 3\u201310 (2013).","journal-title":"Mol. Pharm"},{"key":"BFnnano2015292_CR19","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.jconrel.2013.04.023","volume":"172","author":"I Yildiz","year":"2013","unstructured":"Yildiz, I., Lee, K. L., Chen, K., Shukla, S. & Steinmetz, N. F. Infusion of imaging and therapeutic molecules into the plant virus-based carrier cowpea mosaic virus: Cargo-loading and delivery. J. Controlled Release 172, 568\u2013578 (2013).","journal-title":"J. Controlled Release"},{"key":"BFnnano2015292_CR20","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1093\/intimm\/dxq434","volume":"22","author":"C Costantini","year":"2010","unstructured":"Costantini, C. et al. Neutrophil activation and survival are modulated by interaction with NK cells. Int. Immunol. 22, 827-838 (2010).","journal-title":"Int. Immunol"},{"key":"BFnnano2015292_CR21","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nri3175","volume":"12","author":"DI Gabrilovich","year":"2012","unstructured":"Gabrilovich, D. I., Ostrand-Rosenberg, S. & Bronte, V. Coordinated regulation of myeloid cells by tumours. Nat. Rev. Immunol. 12, 253\u2013268 (2012).","journal-title":"Nat. Rev. Immunol"},{"key":"BFnnano2015292_CR22","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ccr.2009.06.017","volume":"16","author":"ZG Fridlender","year":"2009","unstructured":"Fridlender, Z. G. et al. Polarization of tumor-associated neutrophil (TAN) phenotype by TGF-\u03b2: \u2018N1\u2019 versus \u2018N2\u2019 TAN. Cancer Cell 16, 183\u2013194 (2009).","journal-title":"Cancer Cell"},{"key":"BFnnano2015292_CR23","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nri3024","volume":"11","author":"A Mantovani","year":"2011","unstructured":"Mantovani, A., Cassatella, M. A., Costantini, C. & Jaillon, S. Neutrophils in the activation and regulation of innate and adaptive immunity. Nat. Rev. Immunol. 11, 519\u2013531 (2011).","journal-title":"Nat. Rev. Immunol"},{"key":"BFnnano2015292_CR24","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1158\/0008-5472.CAN-12-3781","volume":"73","author":"M-L Zhu","year":"2013","unstructured":"Zhu, M.-L., Nagavalli, A. & Su, M. A. Aire deficiency promotes TRP-1\u2013specific immune rejection of melanoma. Cancer Res. 73, 2104\u20132116 (2013).","journal-title":"Cancer Res"},{"key":"BFnnano2015292_CR25","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1038\/nm1097","volume":"10","author":"JR Conejo-Garcia","year":"2004","unstructured":"Conejo-Garcia, J. R. et al. Tumor-infiltrating dendritic cell precursors recruited by a \u03b2-defensin contribute to vasculogenesis under the influence of Vegf-A. Nature Med. 10, 950\u2013958 (2004).","journal-title":"Nature Med"},{"key":"BFnnano2015292_CR26","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.4049\/jimmunol.1302030","volume":"192","author":"M-\u00c8 Lebel","year":"2014","unstructured":"Lebel, M.-\u00c8. et al. Nanoparticle adjuvant sensing by TLR7 enhances CD8+ T cell\u2013mediated protection from listeria monocytogenes infection. J. Immunol. 192, 1071\u20131078 (2014).","journal-title":"J. Immunol"},{"key":"BFnnano2015292_CR27","doi-asserted-by":"publisher","first-page":"3724","DOI":"10.4049\/jimmunol.1103312","volume":"188","author":"A Link","year":"2012","unstructured":"Link, A. et al. Innate immunity mediates follicular transport of particulate but not soluble protein antigen. J. Immunol. 188, 3724\u20133733 (2012).","journal-title":"J. Immunol."},{"key":"BFnnano2015292_CR28","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/0042-6822(71)90063-8","volume":"46","author":"GJ Wu","year":"1971","unstructured":"Wu, G. J. & Bruening, G. Two proteins from cowpea mosaic virus. Virology 46, 596\u2013612 (1971).","journal-title":"Virology"},{"key":"BFnnano2015292_CR29","doi-asserted-by":"publisher","first-page":"351","DOI":"10.2217\/nnm.10.136","volume":"6","author":"NF Steinmetz","year":"2011","unstructured":"Steinmetz, N. F., Cho, C.-F., Ablack, A., Lewis, J. D. & Manchester, M. Cowpea mosaic virus nanoparticles target surface vimentin on cancer cells. Nanomed. 6, 351\u2013364 (2011).","journal-title":"Nanomed"},{"key":"BFnnano2015292_CR30","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.1007\/s00018-011-0735-1","volume":"68","author":"A Satelli","year":"2011","unstructured":"Satelli, A. & Li, S. Vimentin in cancer and its potential as a molecular target for cancer therapy. Cell. Mol. Life Sci. 68, 3033\u20133046 (2011).","journal-title":"Cell. Mol. Life Sci"},{"key":"BFnnano2015292_CR31","doi-asserted-by":"publisher","first-page":"e7981","DOI":"10.1371\/journal.pone.0007981","volume":"4","author":"MJ Gonzalez","year":"2009","unstructured":"Gonzalez, M. J., Plummer, E. M., Rae, C. S. & Manchester, M. Interaction of cowpea mosaic virus (CPMV) nanoparticles with antigen presenting cells in vitro and in vivo. PLoS ONE 4, e7981 (2009).","journal-title":"PLoS ONE"},{"key":"BFnnano2015292_CR32","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1172\/JCI37223","volume":"120","author":"J Jablonska","year":"2010","unstructured":"Jablonska, J., Leschner, S., Westphal, K., Lienenklaus, S. & Weiss, S. Neutrophils responsive to endogenous IFN-\u03b2 regulate tumor angiogenesis and growth in a mouse tumor model. J. Clin. Invest. 120, 1151\u20131164 (2010).","journal-title":"J. Clin. Invest"},{"key":"BFnnano2015292_CR33","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.jhep.2010.08.041","volume":"54","author":"D-M Kuang","year":"2011","unstructured":"Kuang, D.-M. et al. Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinoma. J. Hepatol. 54, 948\u2013955 (2011).","journal-title":"J. Hepatol"},{"key":"BFnnano2015292_CR34","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1084\/jem.181.1.435","volume":"181","author":"LA Pekarek","year":"1995","unstructured":"Pekarek, L. A., Starr, B. A., Toledano, A. Y. & Schreiber, H. Inhibition of tumor growth by elimination of granulocytes. J. Exp. Med. 181, 435\u2013440 (1995).","journal-title":"J. Exp. Med"},{"key":"BFnnano2015292_CR35","first-page":"1405","volume":"63","author":"M Wislez","year":"2003","unstructured":"Wislez, M. et al. Hepatocyte growth factor production by neutrophils infiltrating bronchioloalveolar subtype pulmonary adenocarcinoma role in tumor progression and death. Cancer Res. 63, 1405\u20131412 (2003).","journal-title":"Cancer Res"},{"key":"BFnnano2015292_CR36","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1093\/intimm\/dxr007","volume":"23","author":"DSA Abdallah","year":"2011","unstructured":"Abdallah, D. S. A., Egan, C. E., Butcher, B. A. & Denkers, E. Y. Mouse neutrophils are professional antigen-presenting cells programmed to instruct Th1 and Th17 T-cell differentiation. Int. Immunol. 23, 317\u2013326 (2011).","journal-title":"Int. Immunol"},{"key":"BFnnano2015292_CR37","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1084\/jem.20041276","volume":"201","author":"KPJM van Gisbergen","year":"2005","unstructured":"van Gisbergen, K. P. J. M., Sanchez-Hernandez, M., Geijtenbeek, T. B. H. & van Kooyk, Y. Neutrophils mediate immune modulation of dendritic cells through glycosylation-dependent interactions between Mac-1 and DC-SIGN. J. Exp. Med. 201, 1281\u20131292 (2005).","journal-title":"J. Exp. Med"},{"key":"BFnnano2015292_CR38","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.1182\/blood-2006-12-063826","volume":"110","author":"C Beauvillain","year":"2007","unstructured":"Beauvillain, C. et al. Neutrophils efficiently cross-prime naive T cells in vivo. Blood 110, 2965\u20132973 (2007).","journal-title":"Blood"},{"key":"BFnnano2015292_CR39","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1182\/blood-2009-04-216085","volume":"115","author":"M Pelletier","year":"2010","unstructured":"Pelletier, M. et al. Evidence for a cross-talk between human neutrophils and Th17 cells. Blood 115, 335\u2013343 (2010).","journal-title":"Blood"},{"key":"BFnnano2015292_CR40","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1158\/2326-6066.CIR-13-0084","volume":"1","author":"E Clancy-Thompson","year":"2013","unstructured":"Clancy-Thompson, E. et al. Peptide vaccination in montanide adjuvant induces and GM-CSF increases CXCR3 and cutaneous lymphocyte antigen expression by tumor antigen\u2013specific CD8\u2005T cells. Cancer Immunol. Res. 1, 332\u2013339 (2013).","journal-title":"Cancer Immunol. Res"},{"key":"BFnnano2015292_CR41","doi-asserted-by":"publisher","first-page":"469","DOI":"10.4049\/jimmunol.1201209","volume":"190","author":"JR Baird","year":"2013","unstructured":"Baird, J. R. et al. Immune-mediated regression of established B16F10 melanoma by intratumoral injection of attenuated toxoplasma gondii protects against rechallenge. J. Immunol. 190, 469\u2013478 (2013).","journal-title":"J. Immunol"},{"key":"BFnnano2015292_CR42","first-page":"397","volume":"9","author":"G Caramori","year":"2014","unstructured":"Caramori, G., Adcock, I. M., Di Stefano, A. & Chung, K. F. Cytokine inhibition in the treatment of COPD. Int. J. Chron. Obstruct. Pulmon. Dis. 9, 397\u2013412 (2014).","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis"},{"issue":"5","key":"BFnnano2015292_CR43","doi-asserted-by":"publisher","first-page":"e28926","DOI":"10.4161\/onci.28926","volume":"3","author":"Patrick H Lizotte","year":"2014","unstructured":"Lizotte, P. H. et al. Attenuated Listeria monocytogenes reprograms M2-polarized tumor-associated macrophages in ovarian cancer leading to iNOS-mediated tumor cell lysis. Oncoimmunology 3, ( 2014).","journal-title":"OncoImmunology"},{"key":"BFnnano2015292_CR44","doi-asserted-by":"publisher","first-page":"3842","DOI":"10.1158\/0008-5472.CAN-12-1974","volume":"73","author":"JR Baird","year":"2013","unstructured":"Baird, J. R. et al. Avirulent toxoplasma gondii generates therapeutic antitumor immunity by reversing immunosuppression in the ovarian cancer microenvironment. Cancer Res. 73, 3842\u20133851 (2013).","journal-title":"Cancer Res"},{"key":"BFnnano2015292_CR45","doi-asserted-by":"publisher","first-page":"7329","DOI":"10.1158\/0008-5472.CAN-09-0835","volume":"69","author":"UK Scarlett","year":"2009","unstructured":"Scarlett, U. K. et al. In situ stimulation of CD40 and toll-like receptor 3 transforms ovarian cancer\u2013infiltrating dendritic cells from immunosuppressive to immunostimulatory cells. Cancer Res. 69, 7329\u20137337 (2009).","journal-title":"Cancer Res"},{"key":"BFnnano2015292_CR46","first-page":"29","volume":"2","author":"K Hart","year":"2011","unstructured":"Hart, K., Byrne, K., Molloy, M., Usherwood, E. & Berwin, B. IL-10 immunomodulation of myeloid cells regulates a murine model of ovarian cancer. T Cell Biol. 2, 29 (2011).","journal-title":"T Cell Biol"},{"key":"BFnnano2015292_CR47","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/978-1-62703-751-8_11","volume":"1108","author":"F Sainsbury","year":"2014","unstructured":"Sainsbury, F. et al. Genetic engineering and characterisation of Cowpea mosaic virus empty virus-like particles. Methods Mol Biol Clifton NJ. 1108, 139\u2013153 (2014).","journal-title":"Methods Mol Biol Clifton NJ"},{"issue":"5","key":"BFnnano2015292_CR48","doi-asserted-by":"publisher","first-page":"e28926","DOI":"10.4161\/onci.28926","volume":"3","author":"Patrick H Lizotte","year":"2014","unstructured":"Lizotte, P. H., et al. Attenuated Listeria monocytogenes reprograms M2-polarized tumour-associated macrophages in ovarian cancer leading to iNOS-mediated tumour cell lysis. Oncoimmunology 3, e28926 (2014)","journal-title":"OncoImmunology"},{"key":"BFnnano2015292_CR49","doi-asserted-by":"publisher","unstructured":"Pulaski, B. A. & Ostrand-Rosenberg, S. in Current Protocols in Immunology (eds Cooligan, J. E. et al.) 39:20.2:20.2.1\u201320.2.16 (John Wiley & Sons, 2001); \n                    http:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/0471142735.im2002s39\/abstract\n                    \n                  .","DOI":"10.1002\/0471142735.im2002s39\/abstract"}],"container-title":["Nature Nanotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nnano.2015.292.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nnano.2015.292","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nnano.2015.292.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T19:44:46Z","timestamp":1684439086000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nnano.2015.292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,21]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["BFnnano2015292"],"URL":"https:\/\/doi.org\/10.1038\/nnano.2015.292","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726033518.793559559","asserted-by":"object"}]},"ISSN":["1748-3387","1748-3395"],"issn-type":[{"value":"1748-3387","type":"print"},{"value":"1748-3395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,21]]},"assertion":[{"value":"13 May 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have a patent pending for the immunotherapeutic use of the eCPMV nanoparticle.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}